| Dr Rishabh Sharma, MD | |
|
2900 Linden Ln, 200, Silver Spring, MD 20910-1265 | |
| (301) 681-5700 | |
| (301) 681-5599 |
| Full Name | Dr Rishabh Sharma |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 21 Years |
| Location | 2900 Linden Ln, Silver Spring, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356414130 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | D0080107 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Cross Hospital | Silver spring, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associates In Cardiology, P.a. | 8325026586 | 6 |
News Archive
Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.
› Verified 4 days ago
| Entity Name | Associates In Cardiology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134176654 PECOS PAC ID: 8325026586 Enrollment ID: O20040713000834 |
News Archive
Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rishabh Sharma, MD 2900 Linden Ln, 200, Silver Spring, MD 20910-1265 Ph: (301) 681-5700 | Dr Rishabh Sharma, MD 2900 Linden Ln, 200, Silver Spring, MD 20910-1265 Ph: (301) 681-5700 |
News Archive
Mayo Clinic today announced a five-year collaboration with Enterprise Ireland, the Irish enterprise development agency, to advance novel medical technologies originating from Mayo Clinic.
Venous thromboembolism (VTE), encompassing deep-vein thrombosis (DVT), or blood clots in leg veins, and pulmonary embolism (PE), or clots that travel to the lungs, is the most common cause of preventable death in hospital settings. While these clots can be prevented by an approach called VTE prophylaxis, and this reduces mortality by as much as 80%, VTE prophylaxis is not universally prescribed for high-risk patients.
UC San Francisco researchers have for the first time developed a method to precisely control embryonic stem cell differentiation with beams of light, enabling them to be transformed into neurons in response to a precise external cue.
Top Institute Pharma (TI Pharma) enables unique public-private collaborations that are extremely valuable for pharmaceutical research in the Netherlands. This can be read in the Midterm Review (MTR) of the Top Institute, which was published today. In the report, an independent committee chaired by Cees Veerman concludes that TI Pharma is well on its way to achieving the objectives that were determined at the time of its establishment. The institute addresses issues with marked social relevance, attracts international investments and has brought forth a group of quality researchers.
Researchers at UC Irvine have shown that different forms of amyloid beta lead to neural damage in different ways, leading to an increasingly complex view of amyloid toxicity in the Alzheimer brain.
› Verified 4 days ago
Jyotsna Mareedu, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 Forest Glen Rd, Silver Spring, MD 20910 Phone: 301-754-7000 | |
Sean S Saedi, M. D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 12210 Plum Orchard Drive, Suite 212, Silver Spring, MD 20904 Phone: 301-593-6844 Fax: 301-593-3832 | |
Herman B Segal, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 8630 Fenton St Ste 1105, Silver Spring, MD 20910 Phone: 301-681-9095 Fax: 410-367-2114 | |
Dr. Rajeev Batra, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 11120 New Hampshire Ave Ste 300, Silver Spring, MD 20904 Phone: 301-593-9612 Fax: 301-593-6290 | |
Anuradha A Arun, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9801 Georgia Ave, Suite 224, Silver Spring, MD 20902 Phone: 301-593-9800 Fax: 301-593-1061 | |
Dr. Seife Yohannes, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 E West Hwy, #910, Silver Spring, MD 20910 Phone: 301-273-3068 | |
Patricia Keegan, Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 10903 New Hampshire Ave, Building 22, Room 2328, Silver Spring, MD 20903 Phone: 301-796-1387 |